Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 24,348 shares at $39.59 ($977K) on 2021-12-16, disclosed to the SEC on 2021-12-20.
Open-market sale of $977k RCUS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.59 | 4,064 | $161K | 16.5% |
| 2 | $39.59 | 4,064 | $161K | 16.5% |
| 3 | $40.46 | 1,496 | $61K | 6.2% |
| 4 | $40.46 | 1,496 | $61K | 6.2% |
| 5 | $38.79 | 1,580 | $61K | 6.3% |
| 6 | $38.79 | 1,580 |
| $61K |
| 6.3% |
| 7 | $39.67 | 1,008 | $40K | 4.1% |
| 8 | $40.57 | 1,955 | $79K | 8.1% |
| 9 | $40.57 | 1,955 | $79K | 8.1% |
| 10 | $41.42 | 2,575 | $107K | 10.9% |
| 11 | $41.42 | 2,575 | $107K | 10.9% |
| Total | $40.14 avg | 24,348 | $977K | 100% |
| Filing → |
| RCUS | SELL | 2025-10-08 | $1.3M | — | Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-03-20 | $458K | — | Filing → |